279 related articles for article (PubMed ID: 34369886)
1. Evaluation of structural valve deterioration and bioprosthetic valve failure utilizing the new European consensus definition in patients undergoing TAVI with first-generation devices: Outcomes beyond 5 years from a single center in Turkey.
Şentürk B; Dursun H; Çöllüoğlu T; Özdamar H; Ekin T; Tanrıverdi Z; Kaya D
Anatol J Cardiol; 2021 Aug; 25(8):579-587. PubMed ID: 34369886
[TBL] [Abstract][Full Text] [Related]
2. Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
Sathananthan J; Lauck S; Polderman J; Yu M; Stephenson A; Sathananthan G; Moss R; Cheung A; Ye J; Blanke P; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2021 Feb; 97(3):E431-E437. PubMed ID: 32940418
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
[TBL] [Abstract][Full Text] [Related]
4. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
Thyregod HGH; Jørgensen TH; Ihlemann N; Steinbrüchel DA; Nissen H; Kjeldsen BJ; Petursson P; De Backer O; Olsen PS; Søndergaard L
Eur Heart J; 2024 Apr; 45(13):1116-1124. PubMed ID: 38321820
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes and Valve Performance in Patients Undergoing Transcatheter Aortic Valve Implantation.
Stathogiannis K; Synetos A; Latsios G; Karanasos A; Trantalis G; Toskas P; Drakopoulou M; Xanthopoulou M; Karmpalioti M; Simopoulou C; Soulaidopoulos S; Oikonomou G; Benetos G; Tsalamandris S; Kosmas I; Voudris V; Mastrokostopoulos A; Katsimagklis G; Halvatsiotis P; Deftereos S; Tsioufis C; Toutouzas K
Am J Cardiol; 2021 May; 147():80-87. PubMed ID: 33621524
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Echocardiographic Follow-Up After Transcatheter Aortic Valve Implantation to Assess Structural Valve Deterioration and Bioprosthetic Valve Failure.
Giudicatti L; Chieng D; Ireland K; Hillis G; Sanfilippo FM; Yong G
Heart Lung Circ; 2022 Apr; 31(4):559-565. PubMed ID: 34916154
[TBL] [Abstract][Full Text] [Related]
8. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.
Eltchaninoff H; Durand E; Avinée G; Tron C; Litzler PY; Bauer F; Dacher JN; Werhlin C; Bouhzam N; Bettinger N; Candolfi P; Cribier A
EuroIntervention; 2018 Jun; 14(3):e264-e271. PubMed ID: 29599103
[TBL] [Abstract][Full Text] [Related]
9. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
[TBL] [Abstract][Full Text] [Related]
10. Mid-term assessment of structural valve deterioration of perceval S sutureless prosthesis using the last European consensus definition.
Martínez-Comendador JM; Estevez-Cid F; González Barbeito M; Velasco García De Sierra C; Bouzas Mosquera A; Barbeito C; Cuenca Castillo J; Herrera-Noreña J
Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):499-505. PubMed ID: 33881147
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Aortic Bioprosthesis Durability: A Single-Center Experience.
Moroni F; Ziviello F; Federico F; Di Stefano D; Beneduce A; Vella CS; Ancona F; Ingallina G; Ancona M; Ferri LA; Russo F; Bellini B; Agricola E; Chieffo A; Montorfano M
Cardiovasc Revasc Med; 2022 Oct; 43():1-6. PubMed ID: 35690553
[TBL] [Abstract][Full Text] [Related]
12. Developments in transcatheter aortic bioprosthesis durability.
Petronio AS; Giannini C
Expert Rev Cardiovasc Ther; 2019 Dec; 17(12):857-862. PubMed ID: 31847620
[No Abstract] [Full Text] [Related]
13. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.
Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S
Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
Testa L; Latib A; Brambilla N; De Marco F; Fiorina C; Adamo M; Giannini C; Angelillis M; Barbanti M; Sgroi C; Poli A; Ferrara E; Bruschi G; Russo CF; Matteo M; De Felice F; Musto C; Curello S; Colombo A; Tamburino C; Petronio AS; Bedogni F
Eur Heart J; 2020 May; 41(20):1876-1886. PubMed ID: 31904800
[TBL] [Abstract][Full Text] [Related]
15. Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
Ali N; Hildick-Smith D; Parker J; Malkin CJ; Cunnington MS; Gurung S; Mailey J; MacCarthy PA; Bharucha A; Brecker SJ; Hoole SP; Dorman S; Doshi SN; Wiper A; Buch MH; Banning AP; Spence MS; Blackman DJ
Catheter Cardiovasc Interv; 2023 Apr; 101(5):932-942. PubMed ID: 36924015
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
[TBL] [Abstract][Full Text] [Related]
17. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure.
Holy EW; Kebernik J; Abdelghani M; Stämpfli SF; Hellermann J; Allali A; El-Mawardy M; Sachse S; Lüscher TF; Tanner FC; Richardt G; Abdel-Wahab M
EuroIntervention; 2018 Jul; 14(4):e390-e396. PubMed ID: 29741488
[TBL] [Abstract][Full Text] [Related]
18. Structural valve deterioration after transcatheter aortic valve implantation.
Foroutan F; Guyatt GH; Otto CM; Siemieniuk RA; Schandelmaier S; Agoritsas T; Vandvik PO; Bhagra S; Bagur R
Heart; 2017 Dec; 103(23):1899-1905. PubMed ID: 28684441
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
[TBL] [Abstract][Full Text] [Related]
20. The 10-year horizon: Survival and structural valve degeneration in first-generation transcatheter aortic valves.
Erlebach M; Lochbihler S; Ruge H; Feirer N; Trenkwalder T; Burri M; Krane M; Vitanova K; Lange R
Arch Cardiovasc Dis; 2022; 115(6-7):369-376. PubMed ID: 35715323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
